Ephedra OTC Drug Status Consideration Floated By AHPA’s McGuffin
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplement industry may want to consider requesting OTC drug status for ephedra and ephedra/ caffeine combination weight-loss products, American Herbal Products Association President Michael McGuffin suggested Dec. 10
You may also be interested in...
Ephedra Sales Ban Gains Congressional Momentum Following Athlete’s Death
Reps. John Sweeney (R-N.Y.) and Greg Walden (R-Ore.) announced plans to challenge ephedra's safety and address restrictions on the sale of the controversial ingredient following the death of professional baseball player Steve Bechler
Ephedra Sales Ban Gains Congressional Momentum Following Athlete’s Death
Reps. John Sweeney (R-N.Y.) and Greg Walden (R-Ore.) announced plans to challenge ephedra's safety and address restrictions on the sale of the controversial ingredient following the death of professional baseball player Steve Bechler
Ephedra Weight-Loss Claims “Inappropriate,” FDA’s Crawford Says
Weight-loss and energy enhancement claims are "inappropriate" for ephedra-containing products, FDA Acting Commissioner Lester Crawford, PhD, said during an Oct. 8 Senate subcommittee hearing